Beta Drugs Ltd - Prospectus Synopsis

Beta Drugs Ltd RHP

Registered Office : Village Nandpur , , Baddi - 174101 , Himachal Pradesh , India.

Phone : 91-1795-236196 Fax :

Email :info@betadrugslimited.com Website : www.betadrugslimited.com

Public issue of 22,96,000 equity shares of face value of Rs. 10/- each (equity shares) of Beta Drugs Limited (the company Or the issuer) for cash at a price of Rs. 85/- per equity share, including a share premium of Rs. 75/- per equity share (the issue price), aggregating Rs. 19.52 crores (the issue), of which 1,29,600 equity shares of face value of Rs. 10/- each for Cash at a price of Rs. 85/- per equity share, aggregating Rs. 1.10 crores will be reserved for subscription by the market Maker to the issue (the market maker reservation portion). The issue less market maker reservation portion i.e. Issue of 21,66,400 equity shares of face value of Rs. 10 each for cash at a price of Rs. 85/- per equity share, aggregating Rs. 18.42 crores is hereinafter referred to as the net issue. The issue and the net issue will constitute 26.54% and 25.05% Respectively of the fully diluted post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10 each and the issue price of Rs. 85 is 8.5 times of the face value of the Equity shares.

Issue		Money Payable On
Opens On	Closes On	Application	Allotment
9/29/2017 12:00:00 AM	10/4/2017 12:00:00 AM	Rs 85 - 0	Rs 0 - 0
Minimum Application for shares in Nos : 1600 Further Multiples of : 1600

	Rs Cr	Lead Managers to the Issue
Project Cost	19.52	Pantomath Capital Advisors Pvt Ltd
Project Financed through Current Offer	19.52
Post Issue Equity Share Capital	19.52
Issue Price	Rs. 85

Projects
Purchase of new plant and machinery and upgradition of the existing plant and machinery

Promoted By

Listing At

Registrar to the Issue

Vijay Kumar Batra

Link Intime India Pvt Ltd

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

Beta Drugs Ltd - Prospectus Synopsis

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.